Register Login
Register to leave comments
  • News bot May 8, 2026, 11:06 a.m.

    📋 TVARDI THERAPEUTICS, INC. (TVRD) - Financial Results

    Filing Date: 2026-05-08

    Accepted: 2026-05-08 07:05:29

    Event Type: Financial Results

    Event Details:

    TVARDI THERAPEUTICS, INC. (TVRD) Reports the reporting period Financial Results TVARDI THERAPEUTICS, INC. (TVRD) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 19851
      • targeting STAT3 to treat inflammatory and proliferative diseases, today reported its financial and operating results for the first quarter ended March 31, 2026
      • targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need. STAT3 is a central mediator across critical signaling pathways that drive uncontrolled, proliferation, survival and immune dysregulation. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting clinical trials with TTI-109 in healthy volunteers and TTI-101 in hepatocellular carcinoma (NCT0544
      • anticipated in June 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 345.00 727.00 $-382.00 -52.54%
    Current Assets Property Equipment Net 44.00 52.00 $-8.00 -15.38%
    Current Assets Intangible Assets Net 306.00 322.00 $-16.00 -4.97%
    Current Assets Operating Lease Right Of Use Assets 124.00 144.00 $-20.00 -13.89%
    Current Liabilities Accounts Payable 4.62K 3.22K $1.40K +43.52%
    Operating Expenses Loss From Operations 7.05K 4.35K $2.70K +61.94%
    Operating Expenses Interest Income 247.00 275.00 $-28.00 -10.18%
    Operating Expenses Net Loss 6.80K 9.58K $-2.77K -28.97%
    Comprehensive Loss Net Loss 6.80K 9.58K $-2.77K -28.97%
    Prepaid Expenses and Other Current Assets 345.00 727.00 $-382.00 -52.54%
    Property and Equipment, Net 44.00 52.00 $-8.00 -15.38%
    Intangible Assets, Net 306.00 322.00 $-16.00 -4.97%
    Accounts Payable 4.62K 3.22K $1.40K +43.52%
    Operating Lease Liabilities 120.00 116.00 $4.00 +3.45%
    Loss from Operations 7.05K 4.35K $2.70K +61.94%
    Interest Income 247.00 275.00 $-28.00 -10.18%
    Net Loss 6.80K 9.58K $-2.77K -28.97%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TVARDI THERAPEUTICS, INC.
    • Ticker Symbol: TVRD

Search

News categories